MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Core Viewpoint - MacroGenics, Inc. will release its financial results for Q4 and the full year of 2024 on March 20, 2025, after market close, and will host a conference call to discuss these results and recent corporate developments [1]. Group 1: Financial Results Announcement - The financial results for the fourth quarter and full year of 2024 will be announced after market close on March 20, 2025 [1]. - A conference call to discuss the financial results and corporate progress will take place on the same day at 4:30 pm ET [1]. Group 2: Conference Call Information - Participants can register in advance to join the conference call via a provided link, receiving a confirmation email with details on how to join [2]. - A listen-only webcast of the conference call will be available in the Investor Relations section of the company's website [2]. - A recorded replay of the webcast will be accessible shortly after the call and archived for 30 days [2]. Group 3: Company Overview - MacroGenics is a biopharmaceutical company focused on developing monoclonal antibody-based therapeutics for cancer treatment [3]. - The company utilizes proprietary next-generation antibody-based technology platforms to generate its pipeline of product candidates [3]. - MacroGenics has established several strategic collaborations with global pharmaceutical and biotechnology companies [3].